NCT00040677 - A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

January 31, 2004

Conditions

Sickle Cell DiseaseSickle Cell Anemia

Interventions

DRUG

Low Dose ICA-17043

Low dose arm

DRUG

High dose ICA-17043

150 mg Loading Dose; 10 mg daily dose

DRUG

Placebo

Placebo Loading dose capsules and maintenance dose tablets matched 10 mg active treatment group

Trial Locations (19)

Study Site, Birmingham

Study Site, Oakland

Study Site, San Francisco

Study Site, Washington D.C.

Study Site, Augusta

Study Site, Chicago

Study Site, Baltimore

Study Site, Boston

Study Site, Detroit

Study Site, Jackson

Study Site, Brooklyn

Study Site, New York

Study Site, Chapel Hill

Study Site, Durham

Study Site, Philadelphia

Study Site, Pittsburgh

Study Site, Nashville

Study Site, Houston

Study Site, Richmond